Two Biologics Evaluated for Facial, Hand, Foot Dermatitis :

'Lebrikizumab was efficacious in clearing and improving facial and hand dermatitis, burdensome and difficult-to-treat areas, in most patients,' Dr Jenny Murase said, in reporting results at RAD 2023.

Related Keywords

Philadelphia , Pennsylvania , United States , Palo Alto , California , Washington , Oregon , San Francisco , University Of Pennsylvania , American , Eric Simpson , Eli Lilly , Jennye Murase , Chiesa Fuxench , Zelma Chiesa Fuxench , Jonathani Silverberg , Palo Alto Calf Foundation Medical Group , American Academy Of Dermatology , George Washington University , Science University , Oregon Health , University Of California , European Union , Regeneron Pharmaceuticals , Drug Administration , Revolutionizing Atopic Dermatitis , Foundation Medical , New England Journal , Investigator Global Assessment , Peak Pruritus Numerical Rating Scale , Hand Eczema Questionnaire , American Academy , Dermatitis , Monoclonal Antibody , Etuximab , Ituximab , Hands , Drug Development , Foot , Feet , Facial , Biologic Therapy , Adolescent Medicine , Atopic Dermatitis , Pruritus , Pruritis , Pitch , Quality Of Life , Pol , Ealth Related Quality Of Life , Rqol , Corticosteroid , Eczema , Tolerance , Topical Corticosteroids , Interleukins ,